Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies

Volume: 17, Issue: 3, Pages: 265 - 283
Published: Feb 2, 2017
Abstract
Interstitial lung disease (ILD) is a common, devastating pulmonary complication. An increased number of reports suggesting that biological disease modifying antirheumatic drugs (DMARDs) induced or exacerbated ILDs in rheumatoid arthritis (RA) patients has garnered increased attention. Areas covered: This article discusses ILDs induced by or exacerbated during biological therapy in RA patients. The article summarizes the efficacy and safety of a...
Paper Details
Title
Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies
Published Date
Feb 2, 2017
Volume
17
Issue
3
Pages
265 - 283
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.